REQUEST A DEMO
Total
USD $0.00
Search more companies

Lustre Pharmaceuticals Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Lustre Pharmaceuticals Private Limited Profile Updated: April 02, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Lustre Pharmaceuticals Private Limited is a company in India, with a head office in Ahmedabad. It operates in the Pharmaceutical and Medicine Manufacturing industry. The company was established on March 24, 2003. The company’s latest financial report indicates a net sales revenue increase of 6.05% in 2025. Its total assets grew by 10.68% over the same period. Lustre Pharmaceuticals Private Limited’s net profit margin increased by 0.88% in 2025.

Legal Address
15, Barcelona Industrial Estate, Sardar Patel Ring Road, Odhav Circle, Odhav,
Ahmedabad; Gujarat; Postal Code: 382415

Contact Details: Purchase the Lustre Pharmaceuticals Private Limited report to view the information.

Basic Information
Registered Capital:
Purchase the Lustre Pharmaceuticals Private Limited report to view the information.
Financial Auditors:
Purchase the Lustre Pharmaceuticals Private Limited report to view the information.
Incorporation Date:
March 24, 2003
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Company Performance
Financial values in the chart are available after Lustre Pharmaceuticals Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
6.05%
Total Operating Revenue
7.78%
Operating Profit
23.1%
EBITDA
29.87%
Net Profit/Loss for the Period
26.27%
Total Assets
10.68%
Total Equity
12.81%
Operating Profit Margin
1.44%
Net Profit Margin
0.88%
Return on Equity (ROE)
1.21%
Debt / Equity
34.56%
Quick Ratio
1.74%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?